BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang S, Lee S, Lee C, Kim JI, Kim Y. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder. Urology. 2000;55:448-452. [PMID: 10699635 DOI: 10.1016/s0090-4295(99)00474-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Boström PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, Mirtti T, Stakhovskyi O, Laato M, Margel D, Pintilie M, Kuk C, Milosevic M, Zlotta AR, Bristow RG. Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer 2016;2:101-9. [PMID: 27376131 DOI: 10.3233/BLC-150033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 2003;89:1290-7. [PMID: 14520462 DOI: 10.1038/sj.bjc.6601260] [Cited by in Crossref: 152] [Cited by in F6Publishing: 139] [Article Influence: 8.4] [Reference Citation Analysis]
3 Parente P, Coli A, Massi G, Mangoni A, Fabrizi MM, Bigotti G. Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions. J Exp Clin Cancer Res 2008;27:34. [PMID: 18764953 DOI: 10.1186/1756-9966-27-34] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
4 Kirches E. Mitochondrial and nuclear genes of mitochondrial components in cancer. Curr Genomics 2009;10:281-93. [PMID: 19949549 DOI: 10.2174/138920209788488517] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
5 Kang SS, Chun YK, Hur MH, Lee HK, Kim YJ, Hong SR, Lee JH, Lee SG, Park YK. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 2002;93:1123-8. [PMID: 12417042 DOI: 10.1111/j.1349-7006.2002.tb01214.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 4.4] [Reference Citation Analysis]
6 Shorning BY, Griffiths D, Clarke AR. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder. PLoS One 2011;6:e16209. [PMID: 21283818 DOI: 10.1371/journal.pone.0016209] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
7 Deeken R, Engelmann JC, Efetova M, Czirjak T, Müller T, Kaiser WM, Tietz O, Krischke M, Mueller MJ, Palme K, Dandekar T, Hedrich R. An integrated view of gene expression and solute profiles of Arabidopsis tumors: a genome-wide approach. Plant Cell 2006;18:3617-34. [PMID: 17172353 DOI: 10.1105/tpc.106.044743] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
8 Reis H, Tschirdewahn S, Szarvas T, Rübben H, Schmid KW, Grabellus F. Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder. Oncol Lett 2011;2:1149-53. [PMID: 22848280 DOI: 10.3892/ol.2011.394] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
9 Guppy M, Leedman P, Zu X, Russell V. Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 2002;364:309-15. [PMID: 11988105 DOI: 10.1042/bj3640309] [Cited by in Crossref: 175] [Cited by in F6Publishing: 170] [Article Influence: 9.2] [Reference Citation Analysis]
10 Rendic S, Guengerich FP. Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab 2010;11:4-84. [PMID: 20302566 DOI: 10.2174/138920010791110917] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
11 Chiba I, Ogawa K, Morioka T, Shimoji H, Sunagawa N, Iraha S, Nishimaki T, Yoshimi N, Murayama S. Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Oncol Lett 2011;2:21-8. [PMID: 22870123 DOI: 10.3892/ol.2010.199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
12 Mamouni K, Kim J, Lokeshwar BL, Kallifatidis G. ARRB1 Regulates Metabolic Reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells. Cancers (Basel) 2021;13:1809. [PMID: 33920080 DOI: 10.3390/cancers13081809] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ritterson Lew C, Guin S, Theodorescu D. Targeting glycogen metabolism in bladder cancer. Nat Rev Urol 2015;12:383-91. [PMID: 26032551 DOI: 10.1038/nrurol.2015.111] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
14 Hong R, Lim SC. 18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma. World J Gastroenterol 2012; 18(2): 168-174 [PMID: 22253523 DOI: 10.3748/wjg.v18.i2.168] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]